8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2017 / Meta-analysis of RCTs and longitudinal studies
A meta-analysis of 20 studies examined intentional weight loss and cognitive function. Across 13 longitudinal studies (551 participants) and 7 randomized controlled trials (328 treated vs. 140 controls), weight loss was linked to improvements in attention and memory. Longitudinal studies found improvements in executive function, while randomized trials improved language performance.
Veronese N, Facchini S, Stubbs B, et al. Neurosci Biobehav Rev, 2017. PMID 27890688
2017 / Overview of systematic reviews and meta-analyses
An overview was conducted of 12 systematic reviews with meta-analyses of randomized controlled trials evaluating Ginkgo biloba extract (GbE) for dementia or cognitive impairment. Available evidence suggested potentially beneficial effects over placebo on cognitive performance, activities of daily living, and clinical global impression at doses greater than 200 mg/day (usually 240 mg/day) given for 22 weeks or longer, while appearing safe. Doses under 200 mg/day or durations under 22 weeks lacked sufficient evidence for clinically relevant effects. However, the quality of evidence in the included reviews ranged from low to moderate.
Yuan Q, Wang CW, Shi J, et al. J Ethnopharmacol, 2017. PMID 27940086
2017 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis evaluated five RCTs with 183 children with autism spectrum disorder (ASD) comparing omega-3 fatty acid supplementation with placebo or no supplementation. With four exceptions, there were no significant differences in ASD symptoms between groups. Parents' ratings showed improved lethargy symptoms on the Aberrant Behavior Checklist (pooled MD: 1.98; 95% CI: 0.32, 3.63), but worsening of externalizing behavior (pooled MD: -6.22; 95% CI: -10.9, -1.59) and social skills (MD: -7; 95% CI: -13.62, -0.38) on the Behavioral Assessment System for Children. One trial reported improved daily-living scores on the Vineland Adaptive Behavior Scale (MD: 6.2; 95% CI: 0.37, 12.03). Firm conclusions could not be drawn due to the limited number of studies and small sample sizes.
Horvath A, Łukasik J, Szajewska H J Nutr, 2017. PMID 28077731
2017 / Systematic review and meta-analysis
A systematic review and meta-analysis evaluated 42 studies to examine how intentional weight loss affects daytime sleepiness in overweight or obese adults. Fifteen before-and-after studies of surgical weight loss demonstrated large improvements in daytime sleepiness (standardized effect size -0.97, 95% CI -1.21 to -0.72). Twenty-seven studies of non-surgical weight loss interventions found small-to-moderate improvements (standardized effect size -0.40, 95% CI -0.52 to -0.27). A nonlinear association was observed between the amount of weight loss and change in daytime sleepiness.
Ng WL, Stevenson CE, Wong E, et al. Obes Rev, 2017. PMID 28117952
2017 / Systematic review of randomized controlled trials
Nineteen randomized trials evaluated dietary interventions or nutritional supplements in autism spectrum disorder. Omega-3 supplementation did not affect challenging behaviors and was linked to minimal harms (low strength of evidence). Although trials reported parent-rated improvements with gluten/casein-free diets and some improvements with methyl B12 or levocarnitine, data had insufficient strength of evidence to draw firm conclusions, with studies being small and short-term.
Sathe N, Andrews JC, McPheeters ML, et al. Pediatrics, 2017. PMID 28562286
2017 / Umbrella review of meta-analyses of observational studies and RCTs
An umbrella review evaluated evidence from meta-analyses of observational studies and randomized controlled trials on coffee and caffeine consumption. Across 112 observational meta-analyses covering 59 unique outcomes, coffee was associated with a probable decreased risk of breast, colorectal, colon, endometrial, and prostate cancers, cardiovascular disease and mortality, Parkinson's disease, and type-2 diabetes. Across 20 observational meta-analyses covering 14 unique outcomes, caffeine was associated with a probable decreased risk of Parkinson's disease and type-2 diabetes, but an increased risk of pregnancy loss. Among 9 RCT meta-analyses examining 12 acute outcomes, coffee was associated with elevated serum lipids (affected by significant heterogeneity) and caffeine with elevated blood pressure.
Shows an association, not proof of cause and effect.
Grosso G, Godos J, Galvano F, et al. Annu Rev Nutr, 2017. PMID 28826374
2017 / Umbrella review of meta-analyses
An umbrella review analyzed 201 meta-analyses of observational studies and 17 meta-analyses of interventional studies on coffee and multiple health outcomes. Intakes of 3 to 4 cups a day versus none showed the largest relative risk reductions for all-cause mortality (RR 0.83, 95% CI 0.79 to 0.88), cardiovascular mortality (RR 0.81, 95% CI 0.72 to 0.90), and cardiovascular disease (RR 0.85, 95% CI 0.80 to 0.90). High versus low intake was linked to lower incident cancer risk (RR 0.82, 95% CI 0.74 to 0.89) alongside lower risk of neurological, metabolic, and liver conditions. Conversely, high consumption during pregnancy was linked to higher risk of low birth weight (OR 1.31), preterm birth, and pregnancy loss, and coffee was associated with fracture risk in women.
Shows an association, not proof of cause and effect.
Poole R, Kennedy OJ, Roderick P, et al. BMJ, 2017. PMID 29167102
2017 / Meta-analysis of observational studies
A meta-analysis of eight observational studies (three cross-sectional, three cohort, and two case-control) evaluated the relationship between meat consumption and depression. Comparing the highest to lowest intake categories, meat consumption was not significantly linked to depression prevalence across six studies (OR = 0.89, 95% CI: 0.65 to 1.22; P = 0.469). However, across three cohort studies, meat consumption was associated with a moderately higher incidence of depression (RR = 1.13, 95% CI: 1.03 to 1.24; P = 0.013).
Shows an association, not proof of cause and effect.
Zhang Y, Yang Y, Xie MS, et al. BMC Psychiatry, 2017. PMID 29282023
2017 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of randomized controlled trials was conducted to assess the effectiveness of therapeutic exercise in adults with fibromyalgia syndrome. Physical exercise significantly reduced pain (SMD -1.11, 95% CI -1.52 to -0.71; p < 0.001), global well-being (-0.67, 95% CI -0.89 to -0.45; p < 0.001), and symptoms of depression (-0.40, 95% CI -0.55 to -0.24; p < 0.001). Exercise also improved both the physical (SMD 0.77, 95% CI 0.47 to 1.08; p < 0.001) and mental (SMD 0.49, 95% CI 0.27 to 0.71; p < 0.001) components of health-related quality of life.
Sosa-Reina MD, Nunez-Nagy S, Gallego-Izquierdo T, et al. Biomed Res Int, 2017. PMID 29291206
2016 / Systematic review and meta-analysis
A systematic review and meta-analysis was conducted to aggregate findings on vitamin D levels and autism spectrum disorder (ASD). Eleven studies met inclusion criteria, encompassing 870 ASD patients and 782 healthy controls. Levels of serum 25(OH)D in participants with ASD were significantly lower than in healthy controls.
Shows an association, not proof of cause and effect.
Wang T, Shan L, Du L, et al. Eur Child Adolesc Psychiatry, 2016. PMID 26514973
2016 / Meta-analysis
A meta-analysis of 29 independent tests evaluated the relationship between self-weighing and psychological outcomes. There was no association between self-weighing and affect, body-related attitudes, or disordered eating, but there was a small-sized negative association with psychological functioning. Age, obesity status, weight loss extent, duration of self-weighing, and study design influenced at least some outcomes, suggesting self-weighing is largely not linked to adverse psychological outcomes.
Shows an association, not proof of cause and effect.
Benn Y, Webb TL, Chang BP, et al. Health Psychol Rev, 2016. PMID 26742706
2016 / Systematic review and meta-analysis of longitudinal studies
A systematic review and meta-analysis of 21 longitudinal studies examined adiposity and incident dementia. Being obese prior to age 65 was linked to a higher risk of developing dementia (RR 1.41, 95% CI 1.20 to 1.66). Conversely, obesity in participants aged 65 and older was associated with a lower dementia risk (RR 0.83, 95% CI 0.74 to 0.94).
Pedditzi E, Peters R, Beckett N Age Ageing, 2016. PMID 26764391
2016 / Meta-analysis of prospective cohorts
A meta-analysis evaluated 15 prospective cohort studies including 476,569 individuals and 11,074 strokes. Greater saturated fat consumption was linked to lower overall stroke risk (RR 0.89, 95% CI: 0.82-0.96) and fatal stroke risk (RR 0.75, 95% CI: 0.59-0.94). Subgroup reductions appeared in East-Asians, men, individuals with BMI under 24, and intakes under 25 g/day, but not in non-East-Asians, women, or higher intake groups.
Shows an association, not proof of cause and effect.
Cheng P, Wang J, Shao W, et al. Neurol Sci, 2016. PMID 26979840
2016 / Meta-epidemiological review of randomized controlled trials
Researchers analyzed 124 published randomized controlled trials of mindfulness-based therapy, 21 trial registrations, and 36 systematic reviews/meta-analyses to evaluate reporting of positive results and potential biases. Among published trials, 108 (87%) reported at least one positive outcome in the abstract, and 109 (88%) concluded therapy was effective—1.6 times greater than the 65.7 expected based on an effect size of d = 0.55. Additionally, 13 of 21 trial registrations (62%) remained unpublished 30 months post-completion, and none adequately specified a single primary outcome measure with assessment timing. None of the 36 systematic reviews concluded that effect estimates were overestimated due to reporting biases.
Coronado-Montoya S, Levis AW, Kwakkenbos L, et al. PLoS One, 2016. PMID 27058355
2016 / Systematic review and meta-analysis of clinical trials
A systematic review and meta-analyses examined clinical trials evaluating adjunctive nutraceuticals combined with antidepressants for depression. Pooling trials of adjunctive omega-3 versus placebo demonstrated a significant moderate-to-strong beneficial effect, whereas folic acid did not differ significantly from placebo. Replicated trials supported the use of SAMe, methylfolate, omega-3, and vitamin D, while findings for zinc, folic acid, vitamin C, and tryptophan were mixed.
NANO counterpoint →
Sarris J, Murphy J, Mischoulon D, et al. Am J Psychiatry, 2016. PMID 27113121
2016 / Systematic review and meta-analysis
A meta-analysis evaluated the connection between pesticide exposure and Alzheimer's disease across seven studies. Overall pesticide exposure was positively associated with Alzheimer's disease (OR = 1.34; 95% CI = 1.08, 1.67; n = 7), with summary odds ratios of 1.14 (95% CI = 0.94, 1.38; n = 7) for crude models and 1.37 (95% CI = 1.09, 1.71; n = 5) for adjusted models. Sensitivity analyses did not materially alter results, while higher-quality studies tended to report significant associations.
Yan D, Zhang Y, Liu L, et al. Sci Rep, 2016. PMID 27581992
2016 / Systematic review and meta-analysis of cohort studies
A meta-analysis of 16 cohort studies evaluated dietary potassium intake and stroke risk. Comparing the highest with lowest intake categories was associated with a 13% lower stroke risk in blood pressure-adjusted analyses (RR 0.87, 95% CI 0.80-0.94). Spline analysis identified the lowest pooled stroke risk at approximately 90 mmol daily potassium intake (RR 0.78, 95% CI 0.70-0.86 adjusted; RR 0.67, 95% CI 0.57-0.78 unadjusted).
Shows an association, not proof of cause and effect.
Vinceti M, Filippini T, Crippa A, et al. J Am Heart Assoc, 2016. PMID 27792643
2016 / Dose-response meta-analysis of prospective studies
A systematic review and dose-response meta-analysis evaluated 20 prospective studies examining nut consumption and mortality outcomes in adults. A 28 g/day increase in nut intake was associated with reduced risk of coronary heart disease (RR 0.71, 95% CI: 0.63-0.80), cardiovascular disease (RR 0.79, 95% CI: 0.70-0.88), total cancer (RR 0.85, 95% CI: 0.76-0.94), and all-cause mortality (RR 0.78, 95% CI: 0.72-0.84). Inverse associations were also observed for mortality from respiratory disease (RR 0.48), diabetes (RR 0.61), and infectious disease (RR 0.25), with similar findings for tree nuts and peanuts.
Shows an association, not proof of cause and effect.
Aune D, Keum N, Giovannucci E, et al. BMC Med, 2016. PMID 27916000
2015 / Meta-analysis of 10 placebo-controlled RCTs
A meta-analysis evaluated 10 placebo-controlled randomized controlled trials (1,024 participants, duration 6 weeks to 30 months) on soy isoflavone (SIF) supplementation in postmenopausal women. SIF supplementation resulted in a statistically significant overall standardized mean difference (SMD) in summary cognitive function test scores of 0.08 (95% CI, 0.02-0.15; P = 0.014) and in visual memory of 0.10 (95% CI, 0.02-0.18; P = 0.016). Significant SMDs were observed in subgroups for non-US countries (0.12), mean age younger than 60 years (0.16), and treatment duration under 12 months (0.15).
Cheng PF, Chen JJ, Zhou XY, et al. Menopause, 2015. PMID 25003621
2015 / Systematic review and meta-analysis
A systematic review and meta-analysis assessed the short-term effects of music therapy on cognitive function in older adults across five studies. Although individual studies suggested active music therapy improved Mini-Mental State Examination scores, combined meta-analysis showed no statistically significant improvement overall (pooled mean difference 0.73, 95% CI -0.07 to 1.54, P = .07) or for active music therapy specifically (pooled mean difference 0.74, 95% CI -0.08 to 1.56, P = .08). The authors concluded that short-term music therapy does not improve cognitive function in older people and noted the need for higher-quality, long-term studies.
Li HC, Wang HH, Chou FH, et al. J Am Med Dir Assoc, 2015. PMID 25458447
2015 / Systematic review of observational studies
A systematic review of 55 studies was conducted to evaluate demographic, health-related, and psychosocial correlates among people who independently choose to practice yoga. Yoga use was highest among women and individuals with higher socioeconomic status, and it related favorably to psychosocial factors such as coping and mindfulness. Yoga practice often associated with better subjective health and health behaviors, but also with more distress and physical impairment. However, evidence remains sparse, almost all reviewed studies were cross-sectional, and few controlled for potential confounding variables.
Shows an association, not proof of cause and effect.
Park CL, Braun T, Siegel T J Behav Med, 2015. PMID 25627668
2015 / Meta-analysis
A meta-analysis of 12 studies evaluating data from 270 adults with intractable epilepsy was conducted to evaluate the efficacy of and compliance with a ketogenic diet and its main subtypes. Across all ketogenic diet types, the combined efficacy rate was 42% and the combined compliance rate was 45%. For the classical ketogenic diet, combined efficacy was 52% and compliance was 38%. For the modified Atkins diet, combined efficacy was 34% and compliance was 56%.
Ye F, Li XJ, Jiang WL, et al. J Clin Neurol, 2015. PMID 25628734
2015 / Meta-analysis of prospective cohort studies
A meta-analysis evaluated 15 prospective cohorts encompassing 1,020,642 participants. Top-tier adherence to HEI, AHEI, or DASH was associated with lower total mortality (RR 0.78, 95% CI 0.76 to 0.80), cardiovascular events or death (RR 0.78, 95% CI 0.75 to 0.81), malignancies (RR 0.85, 95% CI 0.82 to 0.88), and type 2 diabetes (RR 0.78, 95% CI 0.72 to 0.85). Neurodegenerative conditions showed no significant relationship.
Shows an association, not proof of cause and effect.
Schwingshackl L, Hoffmann G J Acad Nutr Diet, 2015. PMID 25680825
2015 / Meta-analysis of prospective longitudinal studies
A meta-analysis of nine longitudinal studies comprising 20,326 participants aged 65 years or older was conducted to assess the association between physical activity and Alzheimer's disease risk. The fixed effects risk ratio was 0.61 (95% CI 0.52-0.73), indicating a statistically significant overall reduction in risk of Alzheimer's disease in physically active older adults compared to non-active counterparts.
Shows an association, not proof of cause and effect.
Beckett MW, Ardern CI, Rotondi MA BMC Geriatr, 2015. PMID 25887627